s-disease

Documents about s-disease

• Current potential biomarkers for Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis: review of literature#4659Europe PMC
• Huntington's Disease and Huntington's Disease-like 2 (HDL2) in Martinique#235114HAL (France)
• Clinical diagnosis of Alzheimer's disease#6815OpenAlex
• AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)#184947ClinicalTrials.gov
• Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease#290900ClinicalTrials.gov
• Queen's University Investigation of Calcification in Chronic Kidney Disease#143717ClinicalTrials.gov
• MDS clinical diagnostic criteria for Parkinson's disease#7393OpenAlex
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease#6831OpenAlex
• Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease#7394OpenAlex
• Progress of Immunotherapies in Parkinson's Disease#266529Europe PMC
• One‐Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real‐World GETAID Study#147452HAL (France)
• NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease#7359OpenAlex
• Scrolling for science: Assessing the quality and accuracy of Crohn’s disease-related content on Instagram reels#289110PLOS
• Dementia and Alzheimer's Disease: An Overview#167570Digital Commons @ University of Georgia School of Law
• Vitamin D Supplementation in Glomerular Disease#253039ClinicalTrials.gov
• Prevalence of Abnormal Postures in Parkinson's Disease#256983ClinicalTrials.gov
• Differential associations of plasma biomarkers with Alzheimer's disease and small vessel disease: A multimodal imaging study#273347Europe PMC
• Placebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohn's Disease#217065ClinicalTrials.gov
• Imuran Dosing in Crohn's Disease Study#180307ClinicalTrials.gov
• Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease#261494ClinicalTrials.gov
• No room of one’s own: Essays on caregiving and alzheimer's disease#234205Animo Repository
• Theiler's murine encephalomyelitis virus as the infectious agent for a virally induced mouse model of Parkinson's disease#123209Europe PMC
• Genetic testing in parkinson's disease#203526SUNScholar
• A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)#28528ClinicalTrials.gov
• Articulatory kinematics during atypical stop productions in Parkinson’s disease#196174OSF
• Body placement of inertial measurement units differentially affects physical activity assessment accuracy in drug-naïve Parkinson's disease#266516Europe PMC
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.#6922OpenAlex
• Disease modifying treatments for Alzheimer's disease: Clinician perspectives.#159714NCBI PubMed Central
• Accelerating Medicines Partnership® Parkinson's Disease Proteomics: A Comprehensive Resource for Advancing Parkinson's Disease Research.#1059NCBI PubMed Central
• 18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease#28413ClinicalTrials.gov
• Preserving Kidney Function in Children With Chronic Kidney Disease#172451ClinicalTrials.gov
• Tau oligomerization induces nuclear lamina invagination and chromatin remodeling in Alzheimer's disease#127562Europe PMC
• Metformin in Chronic Obstructive Pulmonary Disease#140970ClinicalTrials.gov
• The Feasibility and Practical Utility of Virtual Visits for Patients with Parkinson's Disease in Different World Regions#233277Repositorio Institucional de la Universidad de Burgos (RIUBU)
• Phase I Clinical Study of AV-1959R: Abeta-targeting Anti-Alzheimer's Vaccine#287395ClinicalTrials.gov
• Pain processing and pain assessment in Huntington's disease: Study protocol of the Huntington's disease - PAIN study.#3704NCBI PubMed Central
• Lifestyle factors and plasma biomarkers of Alzheimer's disease: A narrative review#179402HAL (France)
• Dysphagia and Dysphonia in Parkinson’s Disease: Pathophysiological Mechanisms, Treatment Approaches, and Clinical Implications#179606OSF
• The use of memantine for prevention of Alzheimer's disease: Pilot feasibility study rationale and protocol#217710Europe PMC
• The use of memantine for prevention of Alzheimer's disease: Pilot feasibility study rationale and protocol#231262Europe PMC
• PATIENT DERIVED-INDUCED PLURIPOTENT STEM CELL MODEL OF ALZHEIMER'S DISEASE REVEALS DYSREGULATED ANGIOGENESIS AND EARLY CELLULAR SENESCENCE IN HUMAN ENDOTHELIA#288521ScholarBank@NUS
• Alzheimer's disease knowledge graph enhances knowledge discovery and disease prediction.#247544NCBI PubMed Central
• Four decades of Alzheimer's disease discoveries, data, and research resources: The NIH Alzheimer's Disease Research Center Program.#265496NCBI PubMed Central
• Methionine, Homocysteine, and Methylation Levels Predict Cognitive Decline in Alzheimer's Disease#266536Europe PMC
• A Risk Based Approach to Improving Chronic Kidney Disease Management#154777ClinicalTrials.gov
• 18F-FDG and 68Ga-FAPI PET/CT in Crohn's Disease#208397ClinicalTrials.gov
• Combination Osilodrostat and Cabergoline in Cushing's Disease#238247ClinicalTrials.gov
• Association of peripheral and CSF zinc levels with Parkinson's disease: A systematic review and meta-analysis#5269Europe PMC
• Farming exposures and Alzheimer's disease: cross-sectional analysis within the French AGRICAN cohort#202472HAL (France)
• Risk Reduction for Alzheimer's Disease#195454ClinicalTrials.gov